Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women

Breast cancer is the second-leading cause of death among Mexican women >35 years of age. At the molecular level, changes in many genetic pathways have been reported to be associated with this neoplasm. To analyze these changes, we determined gene expression profiles and chromosomal structural alt...

Full description

Saved in:
Bibliographic Details
Published in:Cancer genetics and cytogenetics 2006-10, Vol.170 (2), p.147-151
Main Authors: Valladares, Adán, Hernández, Normand García, Gómez, Fabio Salamanca, Curiel-Quezada, Everardo, Madrigal-Bujaidar, Eduardo, Vergara, Ma. Dolores, Martínez, Mónica Sierra, Arenas Aranda, Diego J.
Format: Article
Language:English
Subjects:
Adult
Aged
Breast Neoplasms - genetics
Chromosome Aberrations
Female
Gene Expression Profiling
Humans
Mexico
Middle Aged
Nucleic Acid Hybridization - methods
Oligonucleotide Array Sequence Analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Breast cancer is the second-leading cause of death among Mexican women >35 years of age. At the molecular level, changes in many genetic pathways have been reported to be associated with this neoplasm. To analyze these changes, we determined gene expression profiles and chromosomal structural alterations in tumors from Mexican women. We obtained mRNA to identify expression profiles with microarray technology, and DNA to determine amplifications and deletions, in 10 fresh sporadic breast tumor biopsies without treatment, as well as in 10 nonaffected breast tissues. Expression profiles were compared with genetic changes observed by comparative genomic hybridization (CGH). We compared the expression profiles against the structural alterations from the studied genes by means of microarrays; at least 17 of these genes correlated with DNA copy number alterations. We found that the following genes were overexpressed: LAMC1, PCTK3, CCNC, CCND1, FGF3, PCTK2, L1CAM, BGN, and PLXNB3 (alias PLEXR). Underexpressed genes included CASP9, FGR, TP73, HSPG2, and ERCC1; genes turned off included FRAP1, EPHA2 (previously ECK), IL12A, E2F5, TNFRSF10B, TNFRSF10A, EFNB3, and BCL2. The results will allow us, in the near future, to outline genes that could serve as diagnostic, prognostic, or target therapy markers for the Mexican population.
ISSN:0165-4608
1873-4456
DOI:10.1016/j.cancergencyto.2006.06.002